awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38287012-1827D2AF-640B-4B8F-BA88-8EAE1BF43547
Q38287012-1827D2AF-640B-4B8F-BA88-8EAE1BF43547
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38287012-1827D2AF-640B-4B8F-BA88-8EAE1BF43547
Definition and management of ruxolitinib treatment failure in myelofibrosis.
P2860
Q38287012-1827D2AF-640B-4B8F-BA88-8EAE1BF43547
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38287012-1827D2AF-640B-4B8F-BA88-8EAE1BF43547
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56e7cf81606d6418d6dbba259a35869db190af2b
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.